| Literature DB >> 27855087 |
Benoît Romain1, Fabian Grass1, Valérie Addor1, Nicolas Demartines1, Martin Hübner1.
Abstract
OBJECTIVE: To compare the enhanced recovery after surgery (ERAS) protocol compliance and clinical outcomes depending on the weekday of surgery. SETTINGS: Cohort of consecutive non-selected patients undergoing elective colorectal surgery from January 2012 to March 2015. This retrospective analysis of our prospective database compared patients operated early in the week (Monday and Tuesday) with patients operated in the second half (late: Thursday, Friday). PRIMARY OUTCOME MEASURES: Compliance with the ERAS protocol, functional recovery, complications and length of stay.Entities:
Keywords: ERAS; complications; enhanced recovery; weekdays
Mesh:
Year: 2016 PMID: 27855087 PMCID: PMC5073485 DOI: 10.1136/bmjopen-2016-011067
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Components of preoperative, intraoperative and postoperative compliance: enhanced recovery items were handled as dichotomous variables. Recommended omissions were accounted for as compliant, if the measure was not performed; for example, no bowel preparation or no nasogastric tube was documented as being compliant with the pathway. Compliance with individual items was calculated as percentage of compliant patients/total patients. IV, intravenous; OPD, postoperative day; PONV, postoperative nausea and vomiting.
Surgical and demographic details of the cohort
| Monday+Tuesday | Thursday+Friday | p Value | |
|---|---|---|---|
| Sex ratio M/F | 197/155 (1.27) | 123/81 (1.52) | 0.18 |
| Mean BMI±SD | 25.51±5.01 | 25.48±5.11 | 0.94 |
| Mean age±SD | 61.34±15.6 | 60.33±15.7 | 0.46 |
| ASA group | |||
| 1–2 | 274 (77.84%) | 52 (74.5%) | 0.23 |
| 3–4 | 78 (22.15%) | 52 (25.5%) | |
| Surgical procedure | 0.32 | ||
| Laparoscopy | 179 (50.8%) | 87 (42.6%) | |
| Open surgery | 83 (23.6%) | 66 (32.4%) | |
| Stoma procedure | 63 (17.9%) | 36 (17.6%) | |
| Conversion | 27 (7.7%) | 15 (7.4%) | |
| Aetiology | |||
| Primary adenocarcinoma | 183 (52%) | 103 (50.5%) | |
| Other primary malignancy | 3 (0.9%) | 4 (1.9%) | |
| Surgery for metastasis or recurrence of any malignancy | 11 (3.1%) | 13 (6.4%) | |
| Benign tumour including polyp(s) | 17 (4.8%) | 9 (4.4%) | 0.56 |
| Crohn's disease | 20 (5.6%) | 4 (2%) | |
| Inflammatory bowel disease | 27 (7.6%) | 11 (5.4%) | |
| Diverticular disease | 44 (12.5%) | 27 (13.2%) | |
| Functional disorder | 18 (5.1%) | 12 (5.9%) | |
| Other benign disorder | 29 (8.2%) | 21 (10.3%) | |
| Rectal resections | 75 (21.6%) | 32 (15.7%) | 0.09 |
| Operative time (minutes) | 179.5 | 193.5 | 0.41 |
| Mean blood loss (mL)±SEM | 149.3±13.04 | 199.2±26.02 | 0.058 |
p<0.05 Indicates statistical significance.
ASA, American Society of Anesthesiologists; BMI, body mass index; F, female; M, male.